![Thais Sielecki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thais Sielecki
Director de Operaciones en Polycore Therapeutics, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Barbara L. Powers | M | - |
Cytokine PharmaSciences, Inc.
![]() Cytokine PharmaSciences, Inc. Pharmaceuticals: MajorHealth Technology Cytokine PharmaSciences, Inc. operates as a biopharmaceutical company. It develops and manufactures drug delivery products. The firm involves in developing controlled-release drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer. The company was founded in June 1999 and is headquartered in Conshohocken, PA. | 20 años |
Kelly Beck | F | 48 |
Polycore Therapeutics, Inc.
![]() Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
Sandhya Kortagere | F | - |
Polycore Therapeutics, Inc.
![]() Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
Jim Harris | M | - |
Polycore Therapeutics, Inc.
![]() Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
Christopher Garabedian | M | 57 |
Polycore Therapeutics, Inc.
![]() Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
Christopher Michael Cashman | M | 67 |
Polycore Therapeutics, Inc.
![]() Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
Dennis F. Willson | M | - |
Cytokine PharmaSciences, Inc.
![]() Cytokine PharmaSciences, Inc. Pharmaceuticals: MajorHealth Technology Cytokine PharmaSciences, Inc. operates as a biopharmaceutical company. It develops and manufactures drug delivery products. The firm involves in developing controlled-release drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer. The company was founded in June 1999 and is headquartered in Conshohocken, PA. | - |
Frederick Callori | M | 56 |
Polycore Therapeutics, Inc.
![]() Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Cameron Macdonald | M | - |
Cytokine PharmaSciences, Inc.
![]() Cytokine PharmaSciences, Inc. Pharmaceuticals: MajorHealth Technology Cytokine PharmaSciences, Inc. operates as a biopharmaceutical company. It develops and manufactures drug delivery products. The firm involves in developing controlled-release drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer. The company was founded in June 1999 and is headquartered in Conshohocken, PA. | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 9 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Thais Sielecki
- Red Personal